EyeGene (Korea) Price on October 24, 2023
185490 Stock | KRW 2,650 5.00 0.19% |
If you're considering investing in EyeGene Stock, it is important to understand the factors that can impact its price. As of today, the current price of EyeGene stands at 2,650, as last reported on the 11th of December 2024, with the highest price reaching 2,775 and the lowest price hitting 2,640 during the day. EyeGene secures Sharpe Ratio (or Efficiency) of -0.16, which denotes the company had a -0.16% return per unit of risk over the last 3 months. EyeGene exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm EyeGene's Mean Deviation of 1.88, variance of 6.28, and Standard Deviation of 2.51 to check the risk estimate we provide.
EyeGene Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
EyeGene |
Sharpe Ratio = -0.1608
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | 185490 |
Estimated Market Risk
2.25 actual daily | 20 80% of assets are more volatile |
Expected Return
-0.36 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.16 actual daily | 0 Most of other assets perform better |
Based on monthly moving average EyeGene is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of EyeGene by adding EyeGene to a well-diversified portfolio.
EyeGene Valuation on October 24, 2023
It is possible to determine the worth of EyeGene on a given historical date. On October 24, 2023 EyeGene was worth 3285.0 at the beginning of the trading date compared to the closed value of 3170.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of EyeGene stock. Still, in general, we apply an absolute valuation method to find EyeGene's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of EyeGene where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against EyeGene's related companies.
Open | High | Low | Close | Volume | |
3,160 | 3,275 | 3,160 | 3,210 | 30,945 | |
10/24/2023 | 3,285 | 3,300 | 3,150 | 3,170 | 46,237 |
3,240 | 3,245 | 3,105 | 3,170 | 28,672 |
Backtest EyeGene | | | EyeGene History | | | EyeGene Valuation | Previous | Next |
EyeGene Trading Date Momentum on October 24, 2023
On October 25 2023 EyeGene was traded for 3,170 at the closing time. The highest price during the trading period was 3,245 and the lowest recorded bid was listed for 3,105 . The volume for the day was 28.7 K. This history from October 25, 2023 did not affect price variability. The overall trading delta to the current price is 1.10% . |
EyeGene Fundamentals Correlations and Trends
By evaluating EyeGene's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among EyeGene's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. EyeGene financial account trend analysis is a perfect complement when working with valuation or volatility modules.About EyeGene Stock history
EyeGene investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for EyeGene is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in EyeGene will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing EyeGene stock prices may prove useful in developing a viable investing in EyeGene
EyeGene Inc., a biotechnology company, engages in the research and development of biopharmaceutical drugs for the treatment and prevention of age-related diseases in South Korea. EyeGene Inc. was founded in 2000 and is headquartered in Seoul, South Korea. Eyegene is traded on Korean Securities Dealers Automated Quotations in South Korea.
EyeGene Stock Technical Analysis
EyeGene technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
EyeGene Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
EyeGene cannot be verified against its exchange. Please verify the symbol is currently traded on KOSDAQ. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
EyeGene December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how EyeGene stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading EyeGene shares will generate the highest return on investment. By undertsting and applying EyeGene stock market strength indicators, traders can identify EyeGene entry and exit signals to maximize returns
EyeGene Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for EyeGene's price direction in advance. Along with the technical and fundamental analysis of EyeGene Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of EyeGene to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.1) | |||
Jensen Alpha | (0.51) | |||
Total Risk Alpha | (0.77) | |||
Treynor Ratio | (0.31) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for EyeGene Stock analysis
When running EyeGene's price analysis, check to measure EyeGene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EyeGene is operating at the current time. Most of EyeGene's value examination focuses on studying past and present price action to predict the probability of EyeGene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EyeGene's price. Additionally, you may evaluate how the addition of EyeGene to your portfolios can decrease your overall portfolio volatility.
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |